Can-Fite BioPharma Ltd. - SPONSORED ADR (CANF)

CUSIP: 13471N409

Q1 2026 13F Holders as of 31 Mar 2026

Share change
+138,279
SEC-reported price per share
$3.10
Indexed holders
13
Value change
+$428,557
Number of buys
13

Security key

13471N409

Report period

Q1 2026

Indexed institutions

13

Top holders

10

Ownership snapshot

Top reported holders of CANF - Can-Fite BioPharma Ltd. - SPONSORED ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Orca Capital AG
Comparable rows
2/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 5% 13 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership Top 2
ARMISTICE CAPITAL, LLC 5%
Orca Capital AG 4.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13D/G
5%
Reported 13D/G · 31 Dec 2024
$528,506
440,422 shares
$0 31 Dec 2024
Orca Capital AG
13D/G
4.1%
Reported 13D/G · 22 Apr 2025
$188,859,240
157,382,700 shares
-$261,140,760 22 Apr 2025
JANE STREET GROUP, LLC
13F
Company
13F
—
denominator unverified
$193,072
205,004 shares
— 31 Dec 2025
RHUMBLINE ADVISERS
13F
Company
13F
—
denominator unverified
$56,372
281,881 shares
— 31 Dec 2025
OSAIC HOLDINGS, INC.
13F
Company
13F
—
denominator unverified
$7,200
36,000 shares
— 31 Dec 2025
UBS Group AG
13F
Company
13F
—
denominator unverified
$4,188
20,942 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
13
Shares
138,279
Indexed holders
13
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2026 vs Q2 2026 Across Filers

Q2 2026 indexed holders
7
Q1 2026 indexed holders
13
Indexed holder difference
6
Investor Q2 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q2 2026 value Q1 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .